Regulation of vascular endothelial growth factor D by orphan receptors hepatocyte nuclear factor-4a and chicken ovalbumin upstream promoter transcription factors 1 and 2

Cancer Research

Volumn 68, Issue 2, 2008, Pages 457-466

  Schäfer, Georgia ^a   Wißmann, Christoph ^a   Hertel, Johannes ^a   Lunyak, Victoria ^b   Höcker, Michael ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 1; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; CYCLIC AMP; GLUCOCORTICOID RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HISTONE DEACETYLASE; HISTONE H3; HISTONE H4; NUCLEAR RECEPTOR COACTIVATOR 2; SYNAPSIN I; TRICHOSTATIN A; VASCULOTROPIN D; CREBBP PROTEIN, HUMAN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; HEPATOCYTE NUCLEAR FACTOR 4; HISTONE; HISTONE ACETYLTRANSFERASE; NCOA2 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME INHIBITION; EPIGENETICS; GENE CONSTRUCT; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; REPORTER GENE; UPREGULATION; CELL CULTURE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROMOTER REGION;

ACETYLATION; BASE SEQUENCE; COUP TRANSCRIPTION FACTOR I; COUP TRANSCRIPTION FACTOR II; CREB-BINDING PROTEIN; GENE EXPRESSION REGULATION; HEPATOCYTE NUCLEAR FACTOR 4; HISTONE ACETYLTRANSFERASES; HISTONES; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR RECEPTOR COACTIVATOR 2; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 39049170399     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-5136     Document Type: Article

References (50)

1. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242-8.
2. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002;2:573-83.
3. Duff SE, Li C, Jeziorska M, et al. Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy. Br J Cancer 2003;89:426-30.
4. Juttner S, Wissmann C, Jons T, et al. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. J Clin Oncol 2006;24:228-40.
5. Niki T, Iba S, Tokunou M, Yamada T, Matsuno Y, Hirohashi S. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res 2000;6:2431-9.
6. O-charoenrat P, Rhys-Evans P, Eccles SA. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 2001;92:556-68.
7. Enholm B, Paavonen K, Ristimaki A, et al. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 1997;14:2475-83.
8. Orlandini M, Oliviero S. In fibroblasts Vegf-D expression is induced by cell-cell contact mediated by cadherin-11. J Biol Chem 2001;276:6576-81.
9. Ristimaki A, Narko K, Enholm B, Joukov V, Alitalo K. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 1998;273:8413-8.
10. Tsai PW, Shiah SG, Lin MT, Wu CW, Kuo ML. Upregulation of vascular endothelial growth factor C in breast cancer cells by heregulin-β1. A critical role of p38/nuclear factor-κB signaling pathway. J Biol Chem 2003;278:5750-9.
11. Orlandini M, Semboloni S, Oliviero S. β-Catenin inversely regulates vascular endothelial growth factor-D mRNA stability. J Biol Chem 2003;278:44650-6.
12. Orlandini M, Marconcini L, Ferruzzi R, Oliviero S. Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc Natl Acad Sci U S A 1996;93:11675-80.
13. Tirona RG, Lee W, Leake BF, et al. The orphan nuclear receptor HNF4a determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat Med 2003;9:220-4.
14. Yamagata K, Furuta H, Oda N, et al. Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature 1996;384:458-60.
15. Parviz F, Matullo C, Garrison WD, et al. Hepatocyte nuclear factor 4α controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet 2003;34:292-6.
16. Mietus-Snyder M, Sladek FM, Ginsburg GS, et al. Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells. Mol Cell Biol 1992;12:1708-18.
17. Pineda T, I, Jamshidi Y, Flavell DM, Fruchart JC, Staels B. Characterization of the human PPARα promoter: identification of a functional nuclear receptor response element. Mol Endocrinol 2002;16:1013-28.
18. Pereira FA, Tsai MJ, Tsai SY. COUP-TF orphan nuclear receptors in development and differentiation. Cell Mol Life Sci 2000;57:1388-98.
19. Zhou C, Tsai SY, Tsai M. From apoptosis to angiogenesis: new insights into the roles of nuclear orphan receptors, chicken ovalbumin upstream promoter-transcription factors, during development. Biochim Biophys Acta 2000;1470:M63-68.
20. Schäfer G, Cramer T, Suske G, Kemmner W, Wiedenmann B, Höcker M. Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1- and Sp3-dependent activation of two proximal GC-rich promoter elements. J Biol Chem 2003;278:8190-8.
21. Moasser MM, Reuter VE, Dmitrovsky E. Overexpression of the retinoic acid receptor-γ directly induces terminal differentiation of human embryonal carcinoma cells. Oncogene 1995;10:1537-43.
22. Qiu Y, Krishnan V, Zeng Z, et al. Isolation, characterization, and chromosomal localization of mouse and human COUP-TF I and II genes. Genomics 1995;29:240-6.
23. Taraviras S, Monaghan AP, Schutz G, Kelsey G. Characterization of the mouse HNF-4 gene and its expression during mouse embryogenesis. Mech Dev 1994;48:67-79.
24. Gurnell M, Wentworth JM, Agostini M, et al. A dominant-negative peroxisome proliferator-activated receptor γ (PPARγ) mutant is a constitutive repressor and inhibits PPARγ-mediated adipogenesis. J Biol Chem 2000;275:5754-9.
25. Sladek FM, Zhong WM, Lai E, Darnell JE, Jr. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev 1990;4:2353-65.
26. Wang LH, Tsai SY, Cook RG, Beattie WG, Tsai MJ, O'Malley BW. COUP transcription factor is a member of the steroid receptor superfamily. Nature 1989;340:163-6.
27. Lunyak VV, Burgess R, Prefontaine GG, et al. Corepressor-dependent silencing of chromosomal regions encoding neuronal genes. Science 2002;298:1747-52.
28. Wingender E, Dietze P, Karas H, Knuppel R. TRANSFAC: a database on transcription factors and their DNA binding sites. Nucleic Acids Res 1996;24:238-41.
29. Nakshatri H and Bhat-Nakshatri P. Multiple parameters determine the specificity of transcriptional response by nuclear receptors HNF-4, ARP-1, PPAR, RAR and RXR through common response elements. Nucleic Acids Res 1998;26:2491-9.
30. Taraviras S, Schutz G, Kelsey G. Generation of inhibitory mutants of hepatocyte nuclear factor 4. Eur J Biochem 1997;244:883-9.
31. Sugiyama T, Wang JC, Scott DK, Granner DK. Transcription activation by the orphan nuclear receptor, chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI). Definition of the domain involved in the glucocorticoid response of the phosphoenolpyruvate carboxykinase gene. J Biol Chem 2000;275:3446-54.
32. Wang JC, Stafford JM, Granner DK. SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4. J Biol Chem 1998;273:30847-50.
33. Yoshida E, Aratani S, Itou H, et al. Functional association between CBP and HNF4 in trans-activation. Biochem Biophys Res Commun 1997;241:664-9.
34. Kim MS, Kwon HJ, Lee YM, et al. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med 2001;7:437-43.
35. Mie LY, Kim SH, Kim HS, et al. Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1α activity. Biochem Biophys Res Commun 2003;300:241-6.
36. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell 1995;83:835-9.
37. Aranda A and Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev 2001;81:1269-304.
38. Kato S, Sasaki H, Suzawa M, et al. Widely spaced, directly repeated PuGGTCA elements act as promiscuous enhancers for different classes of nuclear receptors. Mol Cell Biol 1995;15:5858-67.
39. Fraser JD, Martinez V, Straney R, Briggs MR. DNA binding and transcription activation specificity of hepatocyte nuclear factor 4. Nucleic Acids Res 1998;26:2702-7.
40. Jiang G and Sladek FM. The DNA binding domain of hepatocyte nuclear factor 4 mediates cooperative, specific binding to DNA and heterodimerization with the retinoid X receptor a. J Biol Chem 1997;272:1218-25.
41. Tsai SY and Tsai MJ. Chick ovalbumin upstream promoter-transcription factors (COUP-TFs): coming of age. Endocr Rev 1997;18:229-40.
42. Hwung YP, Crowe DT, Wang LH, Tsai SY, Tsai MJ. The COUP transcription factor binds to an upstream promoter element of the rat insulin II gene. Mol Cell Biol 1988;8:2070-7.
43. Lu XP, Salbert G, Pfahl M. An evolutionary conserved COUP-TF binding element in a neural-specific gene and COUP-TF expression patterns support a major role for COUP-TF in neural development. Mol Endocrinol 1994;8:1774-88.
44. Glass CK and Rosenfeld MG. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 2000;14:121-41.
45. Hermanson O, Glass CK, Rosenfeld MG. Nuclear receptor coregulators: multiple modes of modification. Trends Endocrinol Metab 2002;13:55-60.
46. Xu J, Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol Endocrinol 2003;17:1681-92.
47. Chen HW, Lin RJ, Schiltz RL, et al. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 1997;90:569-80.
48. Dell H and Hadzopoulou-Cladaras M. CREB-binding protein is a transcriptional coactivator for hepatocyte nuclear factor-4 and enhances apolipoprotein gene expression. J Biol Chem 1999;274:9013-21.
49. Ruse MD, Jr., Privalsky ML, Sladek FM. Competitive cofactor recruitment by orphan receptor hepatocyte nuclear factor 4a1: modulation by the F domain. Mol Cell Biol 2002;22:1626-38.
50. Marks PA, Richon VM, Breslow R, Rifkind RA. Histone deacetylase inhibitors as new cancer drugs. Curr Opin Oncol 2001;13:477-83.